Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry

被引:10
|
作者
Bodni, RA
Sapia, S
Galeano, A
Kaminsky, A
机构
[1] Carlos G Durand Hosp, Dermatol Unit, Buenos Aires, DF, Argentina
[2] Mater Hosp, Dept Pathol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Sch Med, Dept Dermatol, Buenos Aires, DF, Argentina
关键词
bone marrow mast cell; flow cytometry; immunophenotype; mast cell disease; MASTOCYTOSIS; ADULTS; DIAGNOSIS;
D O I
10.1046/j.1468-3083.2003.00603.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Mast cell disease has a low prevalence and is difficult to diagnose in the absence of the characteristic skin lesions that usually accompany the condition. Extracutaneous involvement is not easy to assess. There are reports in the recent literature on the use of tryptase as a reliable immunohistochemical marker as well as on the study of the immunophenotype of bone marrow mast cells. The latter is of great help for the diagnosis of systemic involvement as, after the skin, the bone marrow is the organ most commonly affected by the disease. Objective We describe two cases of indolent systemic mast cell disease (SMCD) where flow cytometry was used to identify immunophenotypical characteristics of bone marrow mast cells. Recent advances in the application of this technique prove it can be a good diagnostic tool for assessing systemic involvement of the disease. Patients and methods Two adult subjects with indolent SMCD had multiple clinical symptoms. Cutaneous lesions were the clue to the diagnosis but, subsequently, in the presence of disturbing symptoms, involvement of other organ systems was confirmed. In both cases, the authors used flow cytometry techniques, as described by Escribano et al. (1998) to define the immunophenotype of bone marrow mast cells. Results Both patients were diagnosed with indolent SMCD with cutaneous and bone marrow involvement. Also, they presented visible clues to the presumptive bone, cardiovascular and nervous system involvement. Gastrointestinal manifestations were documented in one case. Conclusions The use of flow cytometry on bone marrow samples from patients with mastocytosis reveals immunophenotypic differences that can serve to allow classification of these subjects in the category of indolent SMCD even though involvement of another organ system may not be thoroughly confirmed.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [1] Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults
    Escribano, L
    Agustín, BD
    Bravo, P
    Navalón, R
    Almeida, J
    Orfao, A
    LEUKEMIA & LYMPHOMA, 1999, 35 (3-4) : 227 - 235
  • [2] Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia
    Escribano, L
    Orfao, A
    Villarrubia, J
    Martin, F
    Madruga, JI
    Cuevas, M
    Velasco, JL
    Rios, A
    SanMiguel, JF
    CYTOMETRY, 1997, 30 (02): : 98 - 102
  • [3] The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease
    Díaz-Agustin, B
    Escribano, L
    Bravo, P
    Herrero, S
    Nuñez, R
    Navalón, R
    Navarro, L
    Torrelo, A
    Cantalapiedra, A
    del Castillo, L
    Villarrubia, J
    Navarro, JL
    San Miguel, JF
    Orfao, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 400 - 405
  • [4] Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples
    Escribano, L
    Orfao, A
    Villarrubia, J
    Diaz-Agustin, B
    Cervero, C
    Rios, A
    Velasco, JL
    Ciudad, J
    Navarro, JL
    San Miguel, JF
    ANALYTICAL CELLULAR PATHOLOGY, 1998, 16 (03) : 151 - 159
  • [5] Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease
    Stevens, EC
    Rosenthal, NS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (02) : 177 - 182
  • [6] Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface
    Escribano, L
    Orfao, A
    Agustin, BD
    Cerveró, C
    Herrero, S
    Villarrubia, J
    Bravo, P
    Torrelo, A
    Montero, T
    Valdemoro, M
    Velasco, JL
    Navarro, JL
    San Miguel, JF
    CYTOMETRY, 1998, 34 (05): : 223 - 228
  • [7] Flow Cytometry Criteria for Systemic Mastocytosis: Bone Marrow Mast Cell Counts Do Not Always Count
    Sanchez-Munoz, Laura
    Morgado, Jose Mario T.
    Alvarez-Twose, Ivan
    Matito, Almudena
    Escribano, Luis
    Teodosio, Cristina
    Jara-Acevedo, Maria
    Garcia-Montero, Andres C.
    Mayado, Andrea
    Orfao, Alberto
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (03) : 404 - 406
  • [8] Bone Marrow Expression of Mast Cell Disorders
    Sanchez-Munoz, Laura
    Filipa Henriques, Ana
    Alvarez-Twose, Ivan
    Matito, Almudena
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (03) : 379 - +
  • [9] Characterization of patients with clonal mast cells in the bone marrow with clinical not otherwise
    Ballul, Thomas
    Sabato, Vito
    Valent, Peter
    Hermine, Olivier
    Lortholary, Olivier
    Rossignol, Julien
    CEREMAST Study Grp
    ECLINICALMEDICINE, 2025, 80
  • [10] Mast Cell Disease Assessment by Flow Cytometric Analysis
    Cortazar, Jacqueline M.
    Dorfman, David M.
    CLINICS IN LABORATORY MEDICINE, 2017, 37 (04) : 869 - +